SCHEMBL4838645

SCHEMBL4838645

COC(=O)Cc1ccc(OS(=O)(=O)C(F)(F)F)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 2/20 0.40
HSD11B1 P28845 1/20 0.40
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
HTR1D P28221 5/20 0.39
HTR1A P08908 4/20 0.39
HTR1B P28222 4/20 0.39
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
CXCR1 P25024 1/20 0.37
PPARD Q03181 2/20 0.37
ACLY P53396 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3918324 0.79 ALDH1A1 (0.54) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6296930 0.79 CYP4F2 (0.54) CXCR2ALDH1A1CXCR1MEN1KMT2A
SCHEMBL8350450 0.78 PTGS1 (0.51) CXCR2HSD11B1KDM4EALDH1A1HPGD
SCHEMBL20539896 0.78 TSHR (0.50) KDM4EALDH1A1HPGDPPARDMEN1
SCHEMBL5537348 0.77 CYP4F2 (0.43) RXRARXRBRXRGALDH1A1HPGD
SCHEMBL2081872 0.77 ALDH1A1 (0.40) CXCR2HTR1DHTR1AHTR1BKDM4E
SCHEMBL29331520 0.77 RXRA (0.51) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL1904920 0.77 SLC7A5 (0.49) KDM4EALDH1A1MEN1KMT2A
SCHEMBL491756 0.76 HSP90AB1 (0.49) CXCR2HSD11B1KDM4EALDH1A1HPGD
SCHEMBL29284728 0.75 CYP4F2 (0.38) DRD2DRD3ALDH1A1HPGDACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 CXCR2 1569/4885HSD11B1 520/4885RXRA 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.